VENOUS THROMBOEMBOLISM
Clinical trials for VENOUS THROMBOEMBOLISM explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Monthly shot vs. daily pills: new hope for cancer patients with dangerous blood clots
Disease control TerminatedThis study tested whether a monthly injection (abelacimab) works better than twice-daily pills (apixaban) to prevent recurring blood clots in people with cancer. It aimed to see if the monthly option reduces both clot recurrence and bleeding risks while being more convenient for …
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Blood clot drug tested in youngest patients
Disease control TerminatedThis study aimed to collect real-world safety and effectiveness data on Pradaxa pellets, a blood thinner medication, for children under 12 years old with blood clots. It observed children in routine medical care who were already prescribed the medication to treat a clot or preven…
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Could a single scan spot hidden blood clots?
Diagnosis TerminatedThis early-stage study tested a new type of PET scan designed to directly detect fresh blood clots in the lungs (pulmonary embolism) and legs (deep vein thrombosis). The goal was to see if this new imaging method could provide a clearer picture of clots compared to current tests.…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE1 • Sponsor: Peter Caravan • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC